Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Melanoma is a significant form of skin cancer.
• Resveratrol (RSV) is a natural polyphenol with potential anti-cancer properties.
• Understanding the mechanisms of RSV's action in melanoma is crucial for therapeutic development.

Purpose of the Study:

• To investigate the inhibitory effects of resveratrol (RSV) on A375 and A431 melanoma cells.
• To assess the impact of RSV on cell viability, apoptosis, and cell cycle progression.
• To determine whether RSV duration or concentration is the primary driver of its effects.

Main Methods:

• Cell viability was measured using the CCK-8 assay.
• Apoptosis was analyzed via flow cytometry and cell morphology observations.
• Cell cycle analysis was performed using flow cytometry and Western blotting for Cyclin D1, Rac1, and PCDH9.
• Statistical analysis, including double variance analysis, was conducted using the R project.

Main Results:

• Resveratrol significantly inhibited proliferation in A375 melanoma cells.
• RSV treatment led to decreased cell viability, increased apoptosis, and cell cycle arrest in A375 cells.
• Statistical analysis indicated that RSV duration strongly influenced Cyclin D1 and PCDH9 expression, while Rac1 was unaffected.

Conclusions:

• Resveratrol inhibits A375 melanoma cell proliferation and induces apoptosis by modulating cell cycle proteins.
• The duration of RSV treatment plays a more critical role than its concentration in achieving these anti-melanoma effects.
• These findings highlight the importance of treatment parameters for optimizing resveratrol-based melanoma therapies.